.jpg)
AusBiotech are pleased to announce the following speakers are confirmed to present at AusBiotech 2009:
Plenary Speakers
Concurrent Speakers
Further details including speakers bios will be available in the coming weeks.
- Dr Bardia Akbari, Global Head Partnering Inflammation and Autoimmune, Roche Pharma Partnering
- Dr Susan Alder, Consultant, SJ Alder Pty Ltd
- Dr Zaheer Anjum, Acting Head, Office of Prescription Medicines, TGA
- Ms Kiara Bechta-Metti, Commercialisation Manager, CSIRO
- Dr Tom Beer, President, IUGG, Transport Biofuels Stream Leader, Energy Transformed Flagship, CSIRO
- Dr C.Glenn Begley, Vice President, Hematology Oncology Research, Amgen
- Mr Geoff Bell, Chief Executive Officer, Microbiogen
- Mr Hershel Berry, Founder & Managing Partner, Blueprint Life Sciences
- Dr Judy Bingham, Senior Director, Regulatory Consulting and Submissions Asia Pacific. Kendle
- Mr Hamish Blair, Senior Adviser, Leadenhall VRG
- Mr David Blake, Co-Editor, Bioshares
- Dr BJ Bormann, Senior Vice President, Business Development & Licensing, Boehringer Ingelheim
- Mr Christopher Boyer, Executive Director, Bio-Link
- Dr Arthur Brandwood, Managing Director, Brandwood Biomedical
- Mr Garold Breit, Executive Director, University of Manitoba Technology Transfer Office
- Mr Peter Brenders, President & CEO, BIOTECanada
- Dr Geoff Brooke, Co Founder & Managing Partner, GBS Venture Partners
- Mr Erinn Broshko, Chief Executive Officer, Med BioGene
- Ms Winna Brown, Australian Life Sciences Leader, Partner, Assurance Business Services, Ernst & Young
- Dr Tran Ngoc Ca, Deputy Director, Deputy Director, National Institute for S&T Policy and Strategy, Ministry of Science and Technology & Director, Secretariat, National Council for S&T Policy, Vietnam
- Dr Deborah Campbell, Executive Medical Director, Amgen Australia
- Ms Janelle Casey, Industry Team Leader, Health, Biotechnology & Wellbeing, Austrade
- Mr Jeffery Castellas, Chief Executive Officer, Clean Technology AustralAsia
- Dr Selena Chaisson, Director of Healthcare Investments, Bailard
- Mr Stephen Chandler, General Manager, Florigene
- Dr Daniel Chelsky, Chief Scientific Officer, Caprion Proteomics
- Dr Benjamin Chen, Managing Director, Burrill & Company
- Mr Trevor Choy, Founder, Choy Lawyers
- Dr Stella Clarke, Chief Executive Officer, The Bio21 Cluster
- Ms Robin Coleman, Director, Advent Pharmaceuticals
- Mr Paul Cohen, Senior Consultant, Brandwood Biomedical
- Dr David Collier, Managing Director, CMEA Capital
- Mr Tony Conaghan, Practice Group Leader, DLA Phillips Fox
- Dr Ross Crittenden, R&D Manager, Biologics and Nutrition, MG Nutritionals, Project Leader, CSIRO - Food and Nutritional Sciences
- Mr Glenn Cross, Chief Operations Officer, AusBiotech
- Mr Grant Davidson, Managing Director, Davidson
- Dr Fred Davis, Managing Director, Invetech
- Dr Nick Day, Professor of Tropical Medicine, Oxford, and Director of the Mahidol Oxford Clinical Research Unit, Bangkok, Thailand
- Dr. Thomas Diefenthal, CEO, BioPark Regensburg, Germany
- Ms Kerry Doyle, Acting Executive Director, Innovation, Research and Policy, Industry and Investment NSW
- Mr Stephen Edelson, Executive Editor, SciBx
- Mr Ian Edvalson, Partner, Wilson Sonsini Goodrich & Rosati
- Dr Les Edye, Principal Research Fellow, Biofuels & Biorefineries, QUT
- Mr Nick Evans, Editor, Biotechnology News
- Dr Leigh Farrell, Vice President Business Development, Biota Holdings
- Ms Lynnette Ferguson, Head Discipline of Nutrition, Faculty of Medical and Health Sciences, The University of Auckland
- Mr Gary Fitt, Deputy Chief, Entomology, CSIRO
- Mr Peter Francis, Partner, Francis Abourizk Lightfowlers
- Mr Lubor Gaal, Head of Europe Search, Bristol Myers Squibb
- Mr Andrew Geering, Principal Plant Pathologist, Industry Services, Queensland Primary Industries and Fisheries
- Dr Michael Gilbert, General Manager, Australian Centre for Plant Functional Genomics
- Mr Keith Glasson, General Manager, Pioneer Hi-Bred Australia
- Dr Harvey Glick, Regional Scientific Affairs Lead, Monsanto
- Mr Andrew Goodsall, Senior Healthcare Analyst, UBS Australia
- Mr Lawrence Gozlan, CEO & Founder, Scientia Capital
- Dr Melissa Grady, Head of Clinical Research, Medical & Regulatory Affairs, AstraZeneca & Co-Chair PIC-RDTF
- Dr Daniel Grant,Head of R&D Business Development, Australia, New Zealand, Singapore, Pfizer Global Research and Development
- Dr Michael Greenberg, Clinical Program Director, Vaccines Develpment, CSL
- Dr Lisa Haile, Partner, DLA Piper
- Dr Jennifer Hannesschlager, Managing Scientific Director, McKenna Long & Aldridge
- Dr Jenny Harry, CEO & Managing Director, Tyrian Diagnostics
- Mr Peter Havel, Director Medical Health Services (MHS) Group, TUV SUD, Japan
- Dr Mark Heffernan, Chief Executive Officer, Opsona Therapeutics
- Ms Joy Hewitt, Director Business Development, Biota Holdings Limited
- Dr Sarah Holland, Global Head, CNS Partnering, Pharma Partnering, Hoffmann-La Roche
- Dr Christopher Holloway, Group Director of Regulatory Affairs, ERA Consulting
- Mr David Hudson, Managing Director, SGA Solutions
- Dr Dianne Jackson-Matthews, Deputy Group Director of Regulatory Affairs, ERA Consulting
- Dr Phil Kearney, Director, Licensing & External Research, Merck, Sharpe and Dohme
- Mr Karl Kelly, Chief Executive Officer, Stirius
- Mr John Kelly
- Dr Andrew Kelly, Executive Director, BioPacific Ventures
- Dr Anna Lavelle, Chief Executive Officer, AusBiotech ltd
- Dr Bruce Lee, Director, Food Future Flagship, CSIRO
- Dr Robyn Lindner, Chief Scientific Officer, Tyrian Diagnostics
- Prof John Lovett, Chairman, CRC for National Plant Biosecurity
- Mr Matt McNamara, Chief Investment Officer, IB Fund
- Dr Andrew MacDonald, Chief Executive Officer, Cytopia
- Ms Sue MacLeman, Chief Executive Officer, Benitec
- Mr Doug McCartney, Director, Science Innovation and Business Development, Manitoba Government
- Dr Andrew Martin, Senior Lecturer, Biostatistics, NHMRC Clinical Trials Centre
- Mr Sean McKay, Executive Director, Composites Innovation Centre
- Mr Peter Molloy, President, Aquarius Consulting
- Dr Ana Maria Moreno, Research Associate, Corelli Consulting
- Dr Colleen Nelson, Executive Director, Australian Prostrate Cancer Research Centre
- Professor Lars Nielsen, Professor & Chair of Biological Engineering, Australian Institute of Bioengineering and Nanotechnology
- Dr Adrian Oates, Vice President, Quality & Regulatory, Universal Biosensors
- Mr Ian O'Hara, Senior Research Scientist and Theme Leader – Bioenergy Queensland University of Technology (QUT) Centre for Tropical Crops and Biocommodities
- Ms Sue O'Malley, Consultant Reimbursement Strategist, Medical Intelligence
- Dr Elliot Parks, President and CEO, Hawaii Biotech Inc
- Prof Tony Peacock, Chief Executive, CRC for Invasive Animals
- Mr Damian Perriman, Vice President Business Development, Verdezyne
- Ms Kate Phillips, Senior Associate, Baker & McKenzie
- Professor Susan Pond
- Mr Scott Power, Associate Director, Research, ABN AMRO Morgans
- Mr David Radford, Executive Director & CEO, Nanosonics
- Dr Deborah Rathjen, CEO & Managing Director, Bionomics
- Dr. Curtis Rempel, Research Development Manager, University of Manitoba
- Mr Craig Rogers,Chief Commercial Officer, Nucleus Network
- Mr Bjorn Roberts, Director of Intelligence and Consumer Safety, Australian Customs & Border Protection Service.
- Ms Beth Roberts, Partner, Hogan & Hartson LLP
- Dr Alan Robertson, Chief Executive Officer, Pharmaxis
- Dr Greg Roger, Chief Executive Officer, Advanced Surgical Design & Manfacturing Ltd
- Dr Jane Ryan, Vice President, Product Development, Biota Holdings Limited
- Mr Peter Sandbach, Head of Communications, Roche Pharma Partnering
- Mr Scott Sarazen, Global Life Sciences Markets Leader, Ernst & Young Boston
- Dr Ebenezer Satyarai, Senior Research Scientist, Nestle
- Dr Rens Scheepers, Associate Professor, Department of Information Systems, The University of Melbourne
- Mr Peter Schutz, Chief Executive, George Weston Technologies
- Mr Dale Seymour, Deputy Secretary, DIIRD
- Dr Sunny Sharma, Senior Managing Director, Asia, OrbiMed Advisors
- Ms Lynda Shelley, Executive Director, Clinical Operations, Novotech
- Dr Evan Siegel, President & Chief Executive Officer, Ground Zero Pharmaceuticals
- Mr Sajai Singh, Resident Partner, J.Sagar Associates
- Dr Danielle Smith, Project Manager, Medicines Development Ltd
- Dr Paul Tan, Chief Executive Officer, LCT
- Mr Ken Taylor, Private Investigator, Trade Mark Investigation Services
- Dr Niall Tebbutt, Consultant Medical Oncologist, Ludwig Institute for Cancer Research
- Mr David Theriault, Business Development Leader Emerging Technology, The DOW Chemical Company
- Associate Professor David Thomas, Peter MacCallum Institute for Cancer Research
- Dr Mervyn Thomas, Managing Director, Emphron Informatics
- Dr Ram A. Vishwakarma, Director, Indian Institute of Integrative Medicine (CSIR), Jammu, India.
- Mr Graeme Wald, Head of Life Sciences Research, Wilson HTM
- Mr Richard Walmsley, Chief Executive Officer, Ingeneus
- Dr Andrew Walter, Operations Manager, AH & GM Walter
- Mr Stephen Walters, Chief Economist, J.P Morgan
- Dr Fintan Walton, Chief Executive & Founder, PharmaVentures
- Dr Linfa Wang, CEO Science Leader, CSIRO Livestock Industries
- Dr Stewart Washer, Director, AusBiotech
- Mr Brad Wheatley, Research Leader, Environment, Boeing Australia
- Ms Elisabeth White, Partner, Baker & McKenzie
- Dr Greg Wiederrecht, Vice President and Head, External Scientific Affairs, Worldwide Licensing & External Research, Merck & Co
- Ms Rebecca Wilson, Principal, Buchan Consulting
- Dr Graeme Woodrow, Chief, Molecular and Health Technologies, CSIRO
- Mr Robert Wulff, Principal, Griffith Hack
- Dr Zeqi Zhou, Vice President, Tianjin International Joint Academy of Biotechnology and Medicine, PR China
